RUNX2 and osteosarcoma: Maria Zielenska et al. found RUNX2 was significantly overexpressed in human Osteosarcoma tissue, and the overexpression was significantly associated with poor chemotherapy response in Osteosarcoma (Sadikovic et al. 2010).